Homocysteine lowering: any use in atherosclerosis?
Prif Awduron: | Antoniades, C, Shirodaria, C, Stefanadis, C, Channon, K |
---|---|
Fformat: | Journal article |
Iaith: | English |
Cyhoeddwyd: |
2007
|
Eitemau Tebyg
-
Homocysteine and coronary atherosclerosis: from folate fortification to the recent clinical trials.
gan: Antoniades, C, et al.
Cyhoeddwyd: (2009) -
MTHFR 677 C>T Polymorphism reveals functional importance for 5-methyltetrahydrofolate, not homocysteine, in regulation of vascular redox state and endothelial function in human atherosclerosis.
gan: Antoniades, C, et al.
Cyhoeddwyd: (2009) -
Vascular Homocysteine Versus 5-Methyl-Tetrahydrofolate As Regulators of Vascular Redox and Endothelial Function in Human Vessels
gan: Antoniades, C, et al.
Cyhoeddwyd: (2009) -
Nanoparticles: a promising therapeutic approach in atherosclerosis.
gan: Antoniades, C, et al.
Cyhoeddwyd: (2010) -
Plasma levels of sCD40-ligand interact with homocysteine biosynthetic pathway and predict eNOS coupling in human vessels: effects on vascular redox state
gan: Antoniades, C, et al.
Cyhoeddwyd: (2008)